1.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Opko Health Inc Borsa (OPK) Ultime notizie
HC Wainwright Boosts Earnings Estimates for OPKO Health - MarketBeat
OPK Stock Price, Quote & Chart | OPKO HEALTH INC (NASDAQ:OPK) - ChartMill
OPKO Health : Notice Annual Meeting of stockholders be held on Thursday, June 18, 2026. - marketscreener.com
Here's why you should hold OPK stock in your portfolio for now - MSN
OPKO gains 15% stake in Nicoya for China RAYALDEE rights - Investing.com UK
[ARS] OPKO HEALTH, INC. SEC Filing - Stock Titan
Board structure and pay detailed in OPKO Health (NASDAQ: OPK) 2026 proxy - Stock Titan
MSN Money - MSN
OPKO gains 15% stake in Nicoya for China RAYALDEE rights By Investing.com - Investing.com South Africa
OPKO Health receives 15% stake in Nicoya for China drug rights - StreetInsider
OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China - marketscreener.com
Kidney drug RAYALDEE targets China as OPKO takes 15% Nicoya stake - Stock Titan
Q1 Earnings Estimate for OPKO Health Issued By HC Wainwright - MarketBeat
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform - Yahoo Finance
OPKO Health (OPK) reports Q1 loss, misses revenue estimates - MSN
OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y - sharewise.com
OPKO Health Down Over 13%, On Pace for Largest Percent Decrease Since January 2024 -- Data Talk - Moomoo
OPKO Health (NASDAQ:OPK) Hits New 1-Year LowShould You Sell? - MarketBeat
This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
H.C. Wainwright reiterates Opko Health stock rating on Q1 results By Investing.com - Investing.com Australia
OPKO Health (NASDAQ:OPK) Downgraded to "Market Perform" Rating by Barrington Research - MarketBeat
H.C. Wainwright reiterates Opko Health stock rating on Q1 results - Investing.com
OPKO Health Q1 2026 Earnings Call: Complete Transcript - Benzinga
OPKO Health Inc (OPK) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing ... By GuruFocus - Investing.com Canada
OPKO Health Q1 2026 Earnings Call Transcript - MarketBeat
OPKO Health Q1 Earnings Call Highlights - MarketBeat
OPK: Clinical pipeline advances and operational improvements drive improved Q1 2026 results - TradingView
OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Earnings call transcript: OPKO Health Q1 2026 reveals revenue decline and stock dip By Investing.com - Investing.com South Africa
Earnings call transcript: OPKO Health Q1 2026 reveals revenue decline and stock dip - Investing.com Nigeria
Earnings Flash (OPK) OPKO Health Posts Q1 Loss of $0.07 per Share, vs. FactSet Est of $0.07 Loss - marketscreener.com
OPKO Health Inc (NASDAQ:OPK) Misses Q1 Revenue Estimates, Shares Slide After Hours - ChartMill
OPKO Health: Q1 Earnings Snapshot - Barchart
OPKO Health (NASDAQ:OPK) Announces Quarterly Earnings Results, Hits Estimates - MarketBeat
Earnings Flash (OPK) OPKO Health, Inc. Reports Q1 Revenue $124.2M, vs. FactSet Est of $130.5M - marketscreener.com
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results - The Manila Times
(OPK) OPKO Health, Inc. Expects Q2 Revenue Range $127.0M$132.0M - marketscreener.com
OPKO Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
OPKO Health (NASDAQ: OPK) Q1 2026 revenue falls as net loss narrows - Stock Titan
OPKO Health (NASDAQ: OPK) Q1 2026 revenue falls as losses narrow and guidance held - Stock Titan
OPKO Health Provides Revenue Guidance for the Second Quarter Ending June 30, 2026; Reaffirms Revenue Guidance for the Full Year Ending December 31, 2026 - marketscreener.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):